trending Market Intelligence /marketintelligence/en/news-insights/trending/IijW7la8wqgFjinafY5FWg2 content esgSubNav
In This List

NewLink Genetics prices common stock offering

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


NewLink Genetics prices common stock offering

NewLink Genetics Corp. priced an underwritten public offering of 5 million common shares at $10.25 apiece.

The company granted underwriters a 30-day option to buy up to an additional 750,000 common shares on the same terms and conditions.

The offering is expected to close by Oct. 6, subject to customary closing conditions.

NewLink Genetics plans to use net proceeds to fund research and development for its product candidates, in addition to working capital and general corporate purposes.

BofA Merrill Lynch and Stifel are acting as joint book-running managers for the offering, with Baird as co-manager.